NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy

Active Not RecruitingN/A

Sponsor: Maastricht Radiation Oncology

Conditions: NSCLC

Countries: Netherlands

There is no detailed information available on benefits and harms of intensified treatment with concurrent RCHT among a subpopulation of elderly patients. Reliable tools are needed to distinguish the subgroup of fit patients from frail patients.

Eligibility overview

Sex: ALL

Age: 75 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion criteria (according to the protocol):

* Any subtype of pathologically proven NSCLC, primary UICC Stage III disease;
* Age ≥ 75 years;
* No surgery or adjuvant chemotherapy for NSCLC in the last year;
* No prior radiotherapy to the ipsilateral thorax or mediastinum;
* No clinical superior vena cava syndrome;
* No diagnosis of other cancer within the last 3-years (except in situ carcinoma's and / or non-melanoma skin cancer);
* Written informed consent

Locations (22)

Almelo, Netherlands
Apeldoorn, Netherlands
Arnhem, Netherlands
Arnhem, Netherlands
Deventer, Netherlands
Ede, Netherlands
Eindhoven, Netherlands
Eindhoven, Netherlands
Enschede, Netherlands
Gorinchem, Netherlands
Gouda, Netherlands
Heerlen, Netherlands
Maastricht, Netherlands
Maastricht, Netherlands
Nijmegen, Netherlands
Roermond, Netherlands
Rotterdam, Netherlands
Rotterdam, Netherlands
The Hague, Netherlands
The Hague, Netherlands
Venlo, Netherlands
Zaandam, Netherlands